Cargando…
Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma
The safety and effectiveness of pazopanib are related to plasma trough concentrations in renal cell carcinoma (RCC); however, data on pazopanib plasma trough concentrations with soft tissue sarcoma (STS) are limited. This study investigated the relationship between plasma trough concentrations and p...
Autores principales: | Aoyama, Takeshi, Nakano, Kenji, Yuasa, Takeshi, Sugiyama, Erika, Okawa, Takako, Ito, Kazuyuki, Azuma, Keiichi, Hashimoto, Koki, Furutani, Ryota, Hiraide, Makoto, Kobayashi, Kazuo, Suzuki, Kenichi, Tomomatsu, Jyunnichi, Tajima, Masataka, Sato, Hitoshi, Hama, Toshihiro, Takahashi, Shunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902386/ https://www.ncbi.nlm.nih.gov/pubmed/36746987 http://dx.doi.org/10.1038/s41598-023-28688-9 |
Ejemplares similares
-
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis
por: Nakano, Kenji, et al.
Publicado: (2016) -
Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
por: Nakano, Kenji, et al.
Publicado: (2019) -
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
por: Sato, Yasuyoshi, et al.
Publicado: (2021) -
Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer
por: Iikura, Yusuke, et al.
Publicado: (2022) -
Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study
por: Yokokawa, Takashi, et al.
Publicado: (2023)